Oncoplastic level II volume displacement surgery for breast cancer: oncological and aesthetic outcomes

• by Marco Sparavigna, Marco Gipponi, Luca Carmisciano, Simonetta Franchelli, Giulia Atzori, Chiara Cornacchia, Raquel Diaz, Federica Murelli, Francesca Depaoli, Daniele Friedman, Piero Fregatti

• March 2, 2023

Implementation of a single-port robotic platform into your colorectal surgery practice: a SAGES colorectal committee task force review of evolving robotic technology and innovations

• by Ankit Sarin, Justin Dourado, Christopher M. Seffren, Upinder S. Sidhu, Poya Pourghaderi, Nathan Aminpour, Elisabeth C. McLemore, Giovanni Dapri, Nawar A. Alkhamesi, Sherief Shawki, Brooklyn Williams, Muhammed Elhadi, Scott Nguyen, Alison Wenholz, Patricia Sylla, Laila Rashidi

• October 12, 2026

Short-term outcomes of a novel anti-reflux biologic flap technique versus double flap technique after laparoscopic proximal gastrectomy: a retrospective cohort study

• by Lindi Cai, Guanglin Qiu, Pengwei Zhao, Gan Li, Junxiang Zhang, Enmeng Li, Yongtai Ma, Yanjun Sun, Mengke Zhu, Xinhua Liao, Xiangming Che, Xuqi Li, Lin Fan

• October 14, 2026

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

• October 15, 2026

• 1 min